Lakefront Biotherapeutics American Depositary Shares
LKFT
119 hedge funds and large institutions have $1.05B invested in Lakefront Biotherapeutics American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 37 reducing their positions, and 42 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 37
0.33% less ownership
Funds ownership: 11.69% → 11.36% (-0.33%)
2% less call options, than puts
Call options by funds: $25.3M | Put options by funds: $26M
17% less funds holding
Funds holding: 143 → 119 (-24)
30% less capital invested
Capital invested by funds: $1.5B → $1.05B (-$453M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$14.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.51M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
+$8.66M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$8.26M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
+$7.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13.5M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$12.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$12M |
| 4 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$10.5M |
| 5 |
Morgan Stanley
New York
|
-$7.13M |
LKFT Hedge Fund Activity: Q3 2020 in Review
119 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2020, worth a combined $1.05B — down 30% from $1.5B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of LKFT and 19 opened new positions — a net loss of 23 holders — while 37 trimmed existing stakes and 44 added.
The largest buyer was Old Mission Capital, adding an estimated $14.1M. The largest seller was Renaissance Technologies, cutting an estimated $13.5M.
- 119 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2020, down from 143 in Q2 2020.
- Funds reported $1.05B of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2020, down 30% quarter-over-quarter.
- 19 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2020 and 42 closed out, a net change of -23 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2020 was Old Mission Capital, an estimated $14.1M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2020 was Renaissance Technologies, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2020.